Published in Int J Colorectal Dis on August 08, 2008
Colorectal cancer: prevention and management of metastatic disease. Biomed Res Int (2014) 0.93
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. World J Gastroenterol (2016) 0.78
Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87. Langenbecks Arch Surg (2014) 0.75
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med (2004) 18.93
Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg (1998) 4.56
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13
Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma. Lancet (1992) 3.12
A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg (1985) 2.66
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol (1998) 2.51
Adjuvant therapy of colorectal cancer. Why we still don't know. JAMA (1988) 2.41
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J Clin Oncol (2005) 2.17
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK) Lancet (1995) 1.60
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology (1994) 1.42
Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg (1990) 1.21
The prophylactic treatment of cancer at the time of operation. Ann Surg (1957) 1.19
Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg (1989) 1.16
Adjuvant cytotoxic liver perfusion for colorectal cancer. Br J Surg (1979) 1.00
Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. Liver Infusion Meta-analysis Group. J Natl Cancer Inst (1997) 0.85
Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver. Cancer (1980) 0.82
Colorectal carcinoma. A survey of 1345 cases 1950-1984. Acta Chir Scand (1985) 0.78
[Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04]. Strahlenther Onkol (2000) 0.75
Structure of the actin-myosin complex and its implications for muscle contraction. Science (1993) 11.30
Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res (1996) 10.46
Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med (2001) 5.10
Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol (2001) 3.83
Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell (2001) 3.29
Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19
Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke (2002) 2.96
Acute and chronic presentation of intestinal nonrotation in adults. Dis Colon Rectum (1994) 2.92
Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res (2000) 2.79
5-Fluorouracil in colorectal cancer, a never ending story. Ann Oncol (1996) 2.69
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry (2002) 2.66
Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64
Zinc oxide nanorod based photonic devices: recent progress in growth, light emitting diodes and lasers. Nanotechnology (2009) 2.48
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45
Gene dosage by quantitative real-time PCR. Biotechniques (1999) 2.45
Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest (2000) 2.42
Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38
Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology (2006) 2.30
Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium. Nucleic Acids Res (1997) 2.28
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol (2008) 2.26
Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res (1990) 2.21
Randomized clinical trial of Lichtenstein's operation versus mesh plug for inguinal hernia repair. Br J Surg (2007) 2.15
Perioperative and postoperative tranexamic acid reduces the local wound complication rate after surgery for breast cancer. Br J Surg (1994) 2.15
Repetitive DNA sequences in Mycoplasma pneumoniae. Nucleic Acids Res (1988) 2.09
Gallstone ileus treated by extracorporeal shockwave lithotripsy. Gastrointest Endosc (1996) 2.08
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06
Patients' estimation of overall treatment burden: why not ask the obvious? J Clin Oncol (2002) 1.93
Physical mapping of the Mycoplasma pneumoniae genome. Nucleic Acids Res (1988) 1.92
Normal modes as refinement parameters for the F-actin model. Biophys J (1995) 1.86
Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer (1980) 1.82
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol (1998) 1.80
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79
Identification and intracellular location of MAGE-3 gene product. Cancer Res (1995) 1.77
Cloning of the complete Mycoplasma pneumoniae genome. Nucleic Acids Res (1989) 1.70
Treatment of the open abdomen with the commercially available vacuum-assisted closure system in patients with abdominal sepsis: low primary closure rate. World J Surg (2008) 1.66
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant (2005) 1.64
Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol (2005) 1.63
[Prospective study of complications of central venous catheters]. Infusionsther Klin Ernahr (1984) 1.63
Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol (2000) 1.63
Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood (1996) 1.62
Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer (2004) 1.60
Management of profound accidental hypothermia with cardiorespiratory arrest. Ann Surg (1982) 1.59
Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas. Hepatogastroenterology (2001) 1.57
Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet (2004) 1.56
Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence. J Bacteriol (1997) 1.56
The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH. J Bacteriol (1995) 1.54
Identification and characterization of hitherto unknown Mycoplasma pneumoniae proteins. Mol Microbiol (1994) 1.51
Physiology, biochemistry, and genetics of the uptake hydrogenase in rhizobia. Annu Rev Microbiol (1987) 1.49
Recent advances in FRET: distance determination in protein-DNA complexes. Curr Opin Struct Biol (2001) 1.48
The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders. Leukemia (2007) 1.47
Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med (1999) 1.46
Performance of office hysteroscopy and endometrial biopsy for detecting endometrial disease in women at risk of human non-polyposis colon cancer: a prospective study. Int J Gynecol Cancer (2008) 1.43
[Telemedicine: perspectives and multidisciplinary approach]. Schweiz Med Wochenschr (2000) 1.42
Transcription profiles of the bacterium Mycoplasma pneumoniae grown at different temperatures. Nucleic Acids Res (2003) 1.42
[Neurogenic appendicopathy: a frequent, almost unknown disease picture. Evaluation of 816 appendices and review of the literature]. Chirurg (2001) 1.41
Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol (1999) 1.40
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Ann Oncol (2010) 1.40
The 'positive-inside rule' applies to thylakoid membrane proteins. FEBS Lett (1991) 1.40
Training aboriginal health care professionals in Manitoba. CMAJ (2000) 1.39
Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases. Inflammation (1993) 1.39
The role of colour flow duplex screening in infra-inguinal vein grafts. Eur J Vasc Surg (1992) 1.39
[Indirect MR arthrography in the diagnosis of rotator cuff lesions]. Rofo (2000) 1.39
[Portal venous thrombosis following splenectomy in portal hypertension: risks and management]. Schweiz Med Wochenschr (1993) 1.39
[Transanal endoscopic microsurgery (TEM): indications and limitations]. Schweiz Med Wochenschr (1994) 1.38
Nucleotide sequence of the 16S rRNA of Mycoplasma hyopneumoniae. Nucleic Acids Res (1987) 1.37
Organization of the ribosomal RNA genes in Mycoplasma hyopneumoniae: the 5S rRNA gene is separated from the 16S and 23S rRNA genes. Mol Gen Genet (1986) 1.36
Sequence divergence in the ORF6 gene of Mycoplasma pneumonia. J Bacteriol (1994) 1.36
Transcription in Mycoplasma pneumoniae. Nucleic Acids Res (2000) 1.34
Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet (1998) 1.34
Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library. Infect Immun (1985) 1.28
Identification and complementation of frameshift mutations associated with loss of cytadherence in Mycoplasma pneumoniae. J Bacteriol (1999) 1.27
In vitro edible muscle protein production system (MPPS): stage 1, fish. Acta Astronaut (2002) 1.26
Identification of gene products of the P1 operon of Mycoplasma pneumoniae. Mol Microbiol (1991) 1.26
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol (2013) 1.26
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun (1989) 1.25
Analysis of transcription and processing signals of the 16S-23S rRNA operon of Mycoplasma hyopneumoniae. Mol Gen Genet (1986) 1.25
The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer (1994) 1.25
Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer (2004) 1.23
Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand (1994) 1.23
Analysis of nutR, a site required for transcription antitermination in phage lambda. Proc Natl Acad Sci U S A (1987) 1.23
The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them. Ann Oncol (2004) 1.23
Load-bearing characteristics of lumbar facets in normal and surgically altered spinal segments. Spine (Phila Pa 1976) (1983) 1.23
Spatial arrangement of gene products of the P1 operon in the membrane of Mycoplasma pneumoniae. Infect Immun (1994) 1.22
Pyogenic infections of the pubic symphysis. Ann Intern Med (1982) 1.22
Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon. Infect Immun (1992) 1.22
The P200 protein of Mycoplasma pneumoniae shows common features with the cytadherence-associated proteins HMW1 and HMW3. Gene (1996) 1.20
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol (2005) 1.20
Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry. Microbiology (2001) 1.19
Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J Clin Oncol (1998) 1.19
Treatment of mesenteric infarction. Br J Surg (1987) 1.19
Sequence analysis of 56 kb from the genome of the bacterium Mycoplasma pneumoniae comprising the dnaA region, the atp operon and a cluster of ribosomal protein genes. Nucleic Acids Res (1996) 1.17